Structures of Zika Virus E & NS1: Relations with Virus Infection and Host Immune Responses
- PMID: 29845526
- DOI: 10.1007/978-981-10-8727-1_6
Structures of Zika Virus E & NS1: Relations with Virus Infection and Host Immune Responses
Abstract
Zika virus (ZIKV), first discovered in the Zika forest in Uganda in 1947 was understudied until the recent explosive epidemic in several South American countries where it has become strongly associated with congenital birth defects leading to severe cranial malformations and neurological conditions. The increase in number of case of microcephaly in newborn children associated with ZIKV infection triggered the World Health Organization to declare the epidemic as a Public Health Emergency of International Concern in February of 2016. ZIKV is a member of the flavivirus genus and is transmitted by Aedes aegypti mosquitoes, however in the current epidemic clear evidence is emerging to suggest the virus can be sexually transmitted from human to human. The differences in epidemiology and manifestations of ZIKV infection during these outbreaks have prompted researchers to investigate mechanisms of dissemination, pathogenesis, and host immune response which contributes significantly to the control of the virus infection. The E and NS1 proteins of ZIKV are the major targets for neutralizing and protective antibodies. In this chapter, we mainly focus on recent research on the crystal structures of the ZIKV E and NS1 proteins, and their relations with virus infection and immune responses. These studies will be helpful to develop novel therapeutics and vaccines for protection and control of ZIKV infection.
Keywords: Crystal structure; E protein; NS1; Neutralizing antibodies; Zika virus.
Similar articles
-
Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes.Nature. 2017 May 25;545(7655):482-486. doi: 10.1038/nature22365. Epub 2017 May 17. Nature. 2017. PMID: 28514450 Free PMC article.
-
Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.J Virol. 2018 Aug 16;92(17):e00701-18. doi: 10.1128/JVI.00701-18. Print 2018 Sep 1. J Virol. 2018. PMID: 29925661 Free PMC article.
-
A Mutation Identified in Neonatal Microcephaly Destabilizes Zika Virus NS1 Assembly in Vitro.Sci Rep. 2017 Feb 15;7:42580. doi: 10.1038/srep42580. Sci Rep. 2017. PMID: 28198446 Free PMC article.
-
[The Recent Epidemic Spread of Zika Virus Disease].Uirusu. 2018;68(1):1-12. doi: 10.2222/jsv.68.1. Uirusu. 2018. PMID: 31105130 Review. Japanese.
-
Zika virus: what we need to know?J Basic Microbiol. 2018 Jan;58(1):3-16. doi: 10.1002/jobm.201700398. Epub 2017 Nov 13. J Basic Microbiol. 2018. PMID: 29131357 Review.
Cited by
-
A Recombinant Zika Virus Envelope Protein with Mutations in the Conserved Fusion Loop Leads to Reduced Antibody Cross-Reactivity upon Vaccination.Vaccines (Basel). 2020 Oct 13;8(4):603. doi: 10.3390/vaccines8040603. Vaccines (Basel). 2020. PMID: 33066262 Free PMC article.
-
Extracellular vesicles in ZIKV infection: Carriers and facilitators of viral pathogenesis?Sci Prog. 2025 Jan-Mar;108(1):368504241312073. doi: 10.1177/00368504241312073. Sci Prog. 2025. PMID: 39835423 Free PMC article. Review.
-
Rearrangement of Actin Cytoskeleton by Zika Virus Infection Facilitates Blood-Testis Barrier Hyperpermeability.Virol Sin. 2021 Aug;36(4):692-705. doi: 10.1007/s12250-020-00343-x. Epub 2021 Feb 3. Virol Sin. 2021. PMID: 33534087 Free PMC article.
-
Zika Virus-Infected Monocyte Exosomes Mediate Cell-to-Cell Viral Transmission.Cells. 2024 Jan 12;13(2):144. doi: 10.3390/cells13020144. Cells. 2024. PMID: 38247836 Free PMC article.
-
Pre-Existing Dengue Immunity Drives a DENV-Biased Plasmablast Response in ZIKV-Infected Patient.Viruses. 2018 Dec 29;11(1):19. doi: 10.3390/v11010019. Viruses. 2018. PMID: 30597938 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical